home / stock / nltx / nltx quote
Last: | $ |
---|---|
Change Percent: | 0.67% |
Open: | $11.80 |
Close: | $11.97 |
High: | $12.40 |
Low: | $11.67 |
Volume: | 263,672 |
Last Trade Date Time: | 02/12/2020 04:42:54 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $11.80 | $11.97 | $12.40 | $11.67 | 263,672 | 02-12-2020 |
$ | $12.55 | $11.89 | $12.75 | $11.67 | 275,924 | 02-11-2020 |
$ | $13.65 | $12.55 | $13.69 | $12.08 | 301,753 | 02-10-2020 |
$ | $13.64 | $13.52 | $13.69 | $13.45 | 149,413 | 02-07-2020 |
$ | $13.62 | $13.64 | $13.65 | $13.29 | 165,359 | 02-06-2020 |
$ | $13.40 | $13.63 | $13.6499 | $13.15 | 264,991 | 02-05-2020 |
$ | $12.48 | $13.21 | $13.71 | $12.44 | 532,906 | 02-04-2020 |
$ | $12.30 | $12.44 | $12.90 | $11.88 | 352,697 | 02-03-2020 |
$ | $11.71 | $12.36 | $12.44 | $11.52 | 324,799 | 01-31-2020 |
$ | $11.25 | $11.76 | $11.99 | $11.1502 | 356,382 | 01-30-2020 |
$ | $11.38 | $11.34 | $11.84 | $11.27 | 225,271 | 01-29-2020 |
$ | $11.20 | $11.38 | $11.88 | $11.20 | 281,388 | 01-28-2020 |
$ | $10.38 | $11.06 | $11.20 | $10.01 | 251,984 | 01-27-2020 |
$ | $11.52 | $10.60 | $11.7466 | $10.0833 | 436,741 | 01-24-2020 |
$ | $11.34 | $11.28 | $12.10 | $11.21 | 317,203 | 01-23-2020 |
$ | $11.12 | $11.38 | $11.94 | $10.87 | 555,101 | 01-22-2020 |
$ | $10.51 | $11.11 | $11.55 | $10.25 | 518,092 | 01-21-2020 |
$ | $10.51 | $10.56 | $10.88 | $10.23 | 327,256 | 01-20-2020 |
$ | $10.51 | $10.56 | $10.88 | $10.23 | 327,256 | 01-17-2020 |
$ | $9.85 | $10.46 | $10.82 | $9.79 | 630,339 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Neoleukin Therapeutics Inc. Company Name:
NLTX Stock Symbol:
NYSE Market:
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its B...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Neoleukin Therapeutics Inc. (NLTX) is expected to report $-0.8 for Q3 2023